coli evolved plasmid displayed a marginal advantage in terms of a higher growth rate, which was borderline significant ( P = 0.063, n = 48).
← all phrases
“borderline significant”
Sighted at
p=0.09
In the literature
A borderline significant association was observed between carrying the AGCC/GGGC diplotype and having a non-screening-detected tumour ( P = 0.063).
The amount of BLG [NP] proliferation was significantly enhanced at a concentration of 0.1–5 μg/mL and remained borderline significant at a concentration of 10–50 μg/mL ( P =0.063).
< 50 g/d) had a borderline significant lower 2h-SG concentrations over time (150, 95% CI = 141–159 vs . 165, 95% CI = 148–166 mg/dL, P = 0.063); no significant difference was observed between the tertile categories of the total, low-fat and high-fat dairy products for FSG over the time.
Logistic regression analysis showed a borderline significant correlation between TCD size (cm 2 ) and failure rate ( P = 0.063; odds ratio = 2.4).
Familial relationship had a borderline significant effect on abortion in model 2 (18.8% vs. 11.1%, p=0.063) when pregnancy period factor was added in model 3 and wave factor in model 4, the effect of familial relationship became significant.
Structural Models No association between LTPA and the CRF dimensions was observed ( p > 0.05) with respect to the borderline significant negative association of −0.15 ( p = 0.063) between CF and LTPA (Rejection of H 1 ).
Regardless, in the current study we did not find that obesity modified gender disparities in likelihood of transplant referral, though this interaction was borderline significant ( P = 0.063) and some other evidence suggests that obese women are less likely to be waitlisted as compared with obese men. 10 An important future direction of our work will be to evaluate obesity and gender interactions across the spectrum of transplant steps.
In Model 2, NHHR demonstrated a borderline significant positive correlation with AAC score ( β = 0.09, 95% CI: −0.005 to 0.18, p = 0.063).
2 ), all masks and respirators conferred statistically significant reductions (p < 0.05) in viral load for fine, coarse, and total aerosols, except that cloth mask was only borderline significant (p = 0.063) for coarse aerosols.
LVM/BMI increased ( P < 0.01) in the HTDD+ group versus the control and in a borderline significant manner ( P = 0.063) in the HTDD+ group versus the HTDD− group (see Table 2 ) [these LAV and LVM results will be published in another article written from this multipurpose study: ( J Hypertens accepted for publication, 2014)]. 3.5.
Kaplan-Meier estimations showed borderline significant difference as to developing death (ten years probabilities for having no event as to death: group1 94%, group2: 97%, p=0.063), significant difference as to CD4 drop<200c/μl (group1 80%, group2: 94%, p=0.0004), but no significant differences as to AIDS (group1 92%, group2: 90%, p=0.219).
On the other hand, the association between haplotype 5 and IGF1 levels was no longer statistically significant in never/past HT users (p = 0.2031) but borderline significant in current HT users (p = 0.0637).
There was borderline significant difference between EA and usual care groups at 4 weeks post-treatment in the ISI ( P = .0639) and PSQI scores ( P = .0556) and a significant difference between them at 2 weeks post-treatment ( P = .0481) and 4 weeks’ follow-up ( P = .0015) in the ISI score.
Newborn total abdominal FFM was likewise positively associated with FFM and FFMI at 3 years and the association with height was borderline significant ( β =0.8, 95% CI: −0.1; 1.7, p = 0.064).
We observed a borderline significant association between histone mutation and OS in univariate analysis ( P = 0.064); compared to H3 wild-type (H3-WT), the outcome was worse in patients with H3.3K27M (hazard ratio = 1.28 (95% CI: 0.81−2.03)) and better in patients with H3.1K27M (hazard ratio = 0.81 (95% CI: 0.46−1.42)).
When comparing their fecal microbiota, OB mice exhibited a significantly higher F/B ratio compared to WT mice only during W1 and W2 (Wilcoxon rank-sum test, P < 0.005, see Additional file 4 : Table S3), and borderline significant higher F/B ratio during W3 ( P = 0.064).
This difference in MPR was significant for IBU Na versus placebo (treatment difference 12.02; 95% CI 5.27–18.77; P = .015) but not for IBU Mot vs placebo (treatment difference 4.50; 95% CI 0.13–8.88; P = .146); the difference in MPR for IBU Na versus IBU Mot at 30 minutes was borderline significant (treatment difference 7.62; 95% CI: −0.38–15.63; P = .064).
A borderline significant correlation was also observed in the distal region (USP5) (r = 0.120, p = 0.064).
In multivariable regression analysis, PYY remained a primary determinant of lumbar BMD after adjusting for age and height (p=0.035, β= -0.36) and a borderline significant predictor of lumbar BMD Z-scores after adjusting for height (p=0.064, β=-0.5).
The TG levels were 1.61 ± 0.63 mmol/L in the obese (BMI ≥ 30 kg/m 2 ) patients with EC and 1.40 ± 0.68 mmol/L in the nonobese (BMI < 30 kg/m 2 ) patients with EC, and the difference was considered to be borderline significant with P = 0.064.
Those who did not score positive for mental fatigue (MFS sum score < 10.5) had higher scores for “Acceptance”, the difference, however, was only borderline significant (p = 0.064).
As shown in Table 3 , gender explained the largest proportion of between-study variance (adjusted R 2 = 45.16%) and demonstrated a borderline significant moderating effect ( p = 0.064).
Interestingly for C1M, although high C1M (Q4) levels were not significantly predictive of OS (Table 2 ), high C1M levels were predictive of PFS by the univariate analysis (HR = 2.13, 95%CI = 1.17–3.88, p = 0.013) and borderline significant with the multivariate analysis (HR = 1.84, 95%CI = 0.97–3.51, p = 0.064) (Additional file 1 : Table S1).
A borderline significant difference was also observed for 3-year BMI ( p = 0.064) and 3-year weight ( p = 0.069) between individuals with zero and one copy of the OPRM1 risk allele.